Skip to content

Novartis AG

NVS NVSEF

CIK 0001114448

← back to feed
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
$11.28B
+17.0% YoY FY Dec 2025
EPS Diluted (TTM)
$5.53
+21.8% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$11.44B
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
1.91B sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings